(702) 683-8946

Monday - Friday 9am to 5pm

triangle
ad1

http://crweworld.com/assets/images/ad/content-delivery-solution.jpg

Our content delivery solution through CRWE WORLDCRWE Press Release and CRWE Tubegives corporations and businesses a vehicle to expand their exposure

Content Delivery Solution (Learn More)

ad3

https://crweworld.com/assets/img/crwe_info.png

CRWE Info ( CRWE.Info ) provides news and updates about Crown Equity Holdings Inc. and the CRWE World platform

www.crwe.info

ad4

https://crweworld.com/assets/images/ad/submit_a_press_release.jpg

Submit Your Press Release/News to the CRWE WORLD Network!. Increase Visibility, Boost Your Business

www.CRWEPressRelease.com






Latest News Releases From The Newsroom

Newsflash: HII Inks Major Multiyear Contract; Cardlytics Beats Estimates

August 01st, 2023

HII's (NYSE: HII) Ingalls Shipbuilding division has been awarded a significant fixed-price incentive multiyear contract for constructing six DDG 51 class ships, with deliveries spanning fiscal years 2023 to 2027.  The contract includes option. Read more

Q2 2023 Earnings: Terex and AMD Outperform Expectations

August 01st, 2023

Terex Corporation (NYSE: TEX) delivered strong second-quarter 2023 financial results, with earnings per share (EPS) of $2.35 and revenues of $1.40 billion, surpassing the consensus estimate of $1.66 on revenues of $1.27 billion. Buoyed by its stro. Read more

Insperity Earnings, Outlook Disappoint; NVIDIA Collaboration Boosts Hesai

August 01st, 2023

Insperity, Inc. (NYSE: NSP) faced disappointing results in the second quarter of 2023, reporting adjusted earnings per share (EPS) of $0.64, falling short of the consensus estimate of $1.25. As a result of the underperformance, the company has rev. Read more

Breaking Q2 Financial Results: Gentherm and Esperion Beat Expectations

August 01st, 2023

Gentherm Incorporated (Nasdaq: THRM) reported strong second quarter 2023 adjusted earnings per share (EPS) of $0.58, surpassing the consensus estimate of $0.52, and revenues of $372.30 million, beating the analysts' expectation of $368.63 million. . Read more

July Vehicle Delivery: Li Auto, XPeng, and NIO By The Numbers

August 01st, 2023

Li Auto Inc. (Nasdaq: LI) reported a remarkable 227.5% year-over-year increase in July vehicle deliveries, reaching 34,134 units. The company surpassed the 30,000 mark for the second consecutive month, with a total of 173,251 deliveries in 2023 as of. Read more

Oshkosh and Boeing Make Waves with Multi-Million Dollar Contracts

July 31st, 2023

Oshkosh Defense LLC, a subsidiary of Oshkosh Corporation (NYSE: OSK), secured a $201,519,794 contract modification for the Family of Medium Trucks.  The Army Contracting Command, Detroit Arsenal, Michigan, is the contracting activity. $OSK. Read more

Lockheed Martin Secures $1.05B+ Defense Contracts, Northrop Grumman Inks $387M+ Defense Deal

July 31st, 2023

Lockheed Martin Corporation (NYSE: LMT) has been awarded two significant defense contracts. The first contract is a $556,114,935 modification to produce Phased Array Tracking Radar to Intercept on Target Advanced Capability-3. The second contract&nbs. Read more

Market Surges: Arista Networks and Woodward Gain Momentum On Upbeat Earnings

July 31st, 2023

Arista Networks, Inc. (NYSE: ANET) delivered strong second-quarter 2023 financial results, with earnings per share (EPS) of $1.58 and revenues of $1.459 billion, surpassing the consensus estimate of $1.44 on revenue of $1.380 billion.  The co. Read more

SEC Charges Hex Founder Richard Heart with Misappropriating Millions of Dollars of Investor Funds from Unregistered Crypto Asset Securities Offerings that Raised more than $1 Billion

July 31st, 2023

FOR IMMEDIATE RELEASE 2023-143 Washington D.C. / CRWE PRESS RELEASE / July 31, 2023 -  The Securities and Exchange Commission today charged Richard Heart (aka Richard Schueler) and three unincorporated entities that he controls, Hex, Pu. Read more

Eagle Pharma Boosts Outlook; Allarity Therapeutics Clinches Key Deal

July 31st, 2023

Shares of Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) surged in pre-market trading as the company raised its full-year 2023 adjusted non-GAAP earnings per share (EPS) guidance.  The new estimated range of $4.40 to $4.70 has been raised from th. Read more